Company intelligence / Profile preview

Ameretat Investment

Menlo Park, California, USA

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Ameretat Investment is a private investment firm and biotechnology holding company based in Menlo Park, California. The firm specializes in early-stage investments and the formation of companies within the life sciences sector, with a particular emphasis on oncology, immunology, and genomic medicine. It is notably associated with the Alizadeh family, including Dr. Arash Alizadeh, and served as a founding investor in Forty Seven Inc., a clinical-stage immuno-oncology company acquired by Gilead Sciences for $4.9 billion. Ameretat Investment focuses on translating high-impact academic research into commercial therapeutic and diagnostic platforms.

Therapeutic areas: Oncology
Modalities: Monoclonal antibodyCell therapy
Industry: Investors

Partnerships

Stanford University

Beyond the preview

Go deeper on Ameretat Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ameretat Investment.

Explore the full profile